Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Step-wise Addition of Insulin Aspart to Insulin Detemir in T2D
NCT00537303Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Oct 2007; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00537303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537303.